BIOMAT Database Logo BIOMAT Database Logo

Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. 1995

M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
Department of Pathology, Erasmus University Rotterdam, The Netherlands.

The product of the neurofibromatosis type 2 (NF2) tumor suppressor gene is a 595-amino-acid protein bearing resemblance to a family of band-4.1-related proteins. These proteins, including ezrin, radixin, and moesin, probably function as molecular linking proteins, connecting the cytoskeleton to the cell membrane. On the grounds of the homology to the ezrin, radixin, and moesin proteins and on the basis of its predicted secondary structure, the NF2 protein is also thought to act as a cytoskeleton-cell membrane linking protein. Using monoclonal antibodies to amino- and carboxyl-terminal synthetic NF2 peptides we demonstrate the co-localization of the NF2 protein with elements of the cytoskeleton in a COS cell model system and in cultured human cells. Furthermore, the presence of the NF2 protein in tissue sections is shown. The monoclonal antibodies specifically stain smooth muscle cells and the stratum granulosum of the human epidermis. In cultured smooth muscle cells the NF2 protein co-localizes with actin stress fibers. Immunoelectron microscopy demonstrates the presence of the NF2 protein associated with keratohyalin granules and to a lesser extent with intermediate filaments in the human epidermis. We conclude that the NF2 protein is indeed associated with multiple elements of the cytoskeleton.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003599 Cytoskeleton The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm. Cytoplasmic Filaments,Cytoskeletal Filaments,Microtrabecular Lattice,Cytoplasmic Filament,Cytoskeletal Filament,Cytoskeletons,Filament, Cytoplasmic,Filament, Cytoskeletal,Filaments, Cytoplasmic,Filaments, Cytoskeletal,Lattice, Microtrabecular,Lattices, Microtrabecular,Microtrabecular Lattices
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000199 Actins Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle. F-Actin,G-Actin,Actin,Isoactin,N-Actin,alpha-Actin,alpha-Isoactin,beta-Actin,gamma-Actin,F Actin,G Actin,N Actin,alpha Actin,alpha Isoactin,beta Actin,gamma Actin

Related Publications

M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
Selective autophagy receptor Joka2 co-localizes with cytoskeleton in plant cells.
January 2014, Plant signaling & behavior,
M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
HIV-1 Nef co-localizes with the astrocyte-specific cytoskeleton protein GFAP in persistently nef-expressing human astrocytes.
February 2001, Journal of neurovirology,
M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
First Co-Occurrence of Griscelli Syndrome Type 2 and Neurofibromatosis Type 1.
June 2024, Molecular syndromology,
M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
September 1997, Journal of cell science,
M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
Co-Manifestations of Genital Neurofibromatosis in a Patient with Neurofibromatosis Type 1.
July 2020, Urology,
M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
[Type 2 neurofibromatosis].
January 2003, Gaceta medica de Mexico,
M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
Neurofibromatosis type 2.
June 2015, Otolaryngologic clinics of North America,
M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
Neurofibromatosis type 2.
October 2003, International journal of clinical practice,
M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
Neurofibromatosis Type 2.
January 2017, Journal of child neurology,
M A den Bakker, and M Tascilar, and P H Riegman, and A C Hekman, and W Boersma, and P J Janssen, and T A de Jong, and W Hendriks, and T H van der Kwast, and E C Zwarthoff
[Neurofibromatosis type 2].
June 2000, Zhonghua er bi yan hou ke za zhi,
Copied contents to your clipboard!